TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.00
-0.0080 (-1.03%)
Apr 29, 2026, 9:43 AM EDT - Market open
TELA Bio Revenue
In the year 2025, TELA Bio had annual revenue of $80.28M with 15.84% growth. TELA Bio had revenue of $20.87M in the quarter ending December 31, 2025, with 18.24% growth.
Revenue (ttm)
$80.28M
Revenue Growth
+15.84%
P/S Ratio
0.43
Revenue / Employee
$384,091
Employees
209
Market Cap
34.90M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Nortech Systems | 118.37M |
| Pulmonx | 90.50M |
| Myomo | 40.93M |
| Cytosorbents | 37.06M |
| electroCore | 32.03M |
| Elutia | 12.29M |
| NeuroOne Medical Technologies | 11.72M |
TELA News
- 7 days ago - TELA Bio to Announce First Quarter 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - TELA Bio Analysts Cut Their Forecasts After Q4 Results - Benzinga
- 5 weeks ago - TELA Bio Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - TELA Bio Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts
- 5 months ago - TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire